Wow Bream on point. I do not foresee any PR for Philippines before it is verified by the hospital with Patients approval. This may be issued by Chiral and info forwarded to Cytodyn. Personally IMO I think it is prudent to wait for all 28 CSP results and not cherry pick data. Individual successful results although magnificent, will be ridiculed. Let’s see as a whole how many issues Leronlimab survived and get the full data as to their condition before Leronlimab, what treatments were used and then after Leronlimab used. No more so called half truths. Call it as is. Then extrapolate the data to include Canada, Brazil, Hungary, EU, and UK. Lastly give the data to the US because it really won’t matter to the FDA. Funny how we are have the only drug Leronlimab which can make a difference in mortality yet still not given coooonnnnndddeeeetiooonaaallll EUA.